Effectiveness of Prolonged Exposure of PTSD in a Community Setting of PTSD Sufferers

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2007 by HaEmek Medical Center, Israel.
Recruitment status was  Not yet recruiting
Information provided by:
HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
First received: August 27, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted

Introduction: Efforts to bridge the gap between research based treatment modalities advancements and clinical practice have received the highest priority in the research community. In the child psychiatry field there is an urging need to promote bridging this gap.

Parents and child health providers hesitate to refer children to child psychiatrist due to stigma but also due to lack of awareness of available and efficient treatment options. In the field of trauma treatment another reason for lack of treatment is lack of recognition of trauma related symptoms in children.

After the second Lebanon war scarce referrals to psychiatric clinics have been registered and access to treatment is low as indicated by 20 referrals in the past year to Emek Hospital.

We propose to explore the effectiveness of well-established adult treatment for PTSD, the Prolonged Exposure (PE), in community-based general pediatric clinics, serving an underprivileged diverse population.


Twenty children age 6 to 18 attending general pediatric clinic and in Afula region will included.

children will be diagnosed using the Hebrew translation of the Childhood version of the Schedule for Affective Disorders and Schizophrenia (Apter et al., 1989 Children will receive the Children's Depression Inventory (CDI) and the. CPSS All subjects will be treated with a manualized 12-week Prolonged Exposure protocol Ratings will be made at baseline, 6weeks, and 12 weeks using CDI and CPSS


1. PE adapted for pediatric population will be effective in treating single-event traumas in a community setting.

Condition Intervention
Post Traumatic Stress Disorder
Anxiety Disorder
Behavioral: Prolonged exposure

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic

Resource links provided by NLM:

Further study details as provided by HaEmek Medical Center, Israel:

Primary Outcome Measures:
  • CDI questionaire [ Time Frame: 12 weeks ]

Estimated Enrollment: 20
  Show Detailed Description


Ages Eligible for Study:   6 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Children age 6 to 18
  • Language spoken: Hebrew
  • DSM- IV R diagnosis: PTSD
  • Anxiety disorder

Exclusion Criteria:

  • Children presenting with psychotic symptoms,
  • Children presenting with mental retardation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00521768

Contact: Ziva Bracha, MD 972-4-6494138 ext 4138 bracha_zi@clalit.org.il

HaEmek Medical Center - Psychiatry Department Not yet recruiting
Afula, Israel, 18101
Contact: Ziva Bracha, MD    972-4-6494138 ext 4138    bracha_zi@clalit.org.il   
Sponsors and Collaborators
HaEmek Medical Center, Israel
Principal Investigator: Ziva Bracha, MD HaEmek MC
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00521768     History of Changes
Other Study ID Numbers: CT20
Study First Received: August 27, 2007
Last Updated: August 27, 2007
Health Authority: Israel: Ministry of Health

Keywords provided by HaEmek Medical Center, Israel:
Post traumatic stress disorder
Anxiety disorder
Comunity base intervention
Behavioural treatment

Additional relevant MeSH terms:
Anxiety Disorders
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Mental Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on October 22, 2014